MBrace Therapeutics Raises $85 Million Series B Financing to Advance Oncology Pipeline of Innovative
- Chang-Han Lee
- Nov 28, 2023
- 1 min read
– Oversubscribed Series B round led by TPG includes prominent group of new and existing investors, bringing total raised to-date to over $110 million
– Funding supports rapid clinical development of targeted ADC therapeutics in difficult-to-treat cancers
– Chris LeMasters joins as Independent Board Member, bringing 25 years of biotech experience
Komentáre